Skip to main content
hello world

Closing Bell: Biosyent Inc down on Wednesday (RX)

Automated Summaries - The Globe and Mail - Wed Jul 17, 4:01PM CDT

In today's trading, shares of Biosyent Inc opened at $10.00 and closed at $10.00. It traded at a low of $10.00 to a high of $10.10.

The price lost -1.48% from the previous day's close of $10.15.

During the day across North America, the TSX Composite closed 1.07% at 22995.39, the S&P 500 closed 0.64% at 5667.20, the Dow Jones Industrial Average closed 1.85% at 40954.48 and the Nasdaq Composite closed 0.20% at 18509.34.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

Trading volume was 2,610 on 9 total trades. On average, Biosyent Inc has traded 2,861 shares over the last 5-days and 6,802 year-to-date.

The TSX-V market on the whole today saw 2,100 price advancers against 3,108 declines and 117 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $10.75 (June 21,2024) and low as $7.41 (July 21,2023). Moreover, the shares have soared 33.16 percent in the last year, while in 2024, they have advanced 8.46%.

It announced a 0.04 dividend on May 16/24, with an May 31/24 ex-date and June 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $117.58 million on a float of 11,584 shares outstanding. Its annual EPS is $0.58.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Based on 1.00 analysts, Biosyent Inc gets an average recommendation of "Moderate Buy" according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..